The authors of a recent journal article believe that most doctors and clinical trial sponsors would not object to changes in regulations requiring doctors to disclose financial incentives to their patients.
Limiting the right of patients to make their own medical decisions can be justified only when a patient lacks the competence to do so or pose a threat to others.